| Advances in targeted nanotherapeutics: from bioconjugation to biomimicry DM Valcourt, J Harris, RS Riley, M Dang, J Wang, ES Day Nano research 11, 4999-5016, 2018 | 64 | 2018 |
| Nanoparticle-mediated co-delivery of Notch-1 antibodies and ABT-737 as a potent treatment strategy for triple-negative breast cancer DM Valcourt, MN Dang, MA Scully, ES Day ACS nano 14 (3), 3378-3388, 2020 | 63 | 2020 |
| Using Gold Nanoparticles To Disrupt the Tumor Microenvironment: An Emerging Therapeutic Strategy JR Melamed, RS Riley, DM Valcourt, ES Day ACS nano, 2016 | 62 | 2016 |
| IR820‐loaded PLGA nanoparticles for photothermal therapy of triple‐negative breast cancer DM Valcourt, MN Dang, ES Day Journal of Biomedical Materials Research Part A 107 (8), 1702-1712, 2019 | 48 | 2019 |
| Polymer nanocarriers for MicroRNA delivery CH Kapadia, B Luo, MN Dang, ND Irvin‐Choy, DM Valcourt, ES Day Journal of applied polymer science 137 (25), 48651, 2020 | 39 | 2020 |
| Dual regulation of miR-34a and Notch signaling in triple-negative breast cancer by antibody/miRNA nanocarriers DM Valcourt, ES Day Molecular Therapy-Nucleic Acids 21, 290-298, 2020 | 37 | 2020 |
| Quantification of siRNA duplexes bound to gold nanoparticle surfaces JR Melamed, RS Riley, DM Valcourt, MM Billingsley, NL Kreuzberger, ... Biomedical Nanotechnology: Methods and Protocols, 1-15, 2017 | 24 | 2017 |
| Nanoparticles for manipulation of the developmental Wnt, Hedgehog, and Notch signaling pathways in cancer DM Valcourt, MN Dang, J Wang, ES Day Annals of biomedical engineering 48 (7), 1864-1884, 2020 | 21 | 2020 |
| Best practices for preclinical in vivo testing of cancer nanomedicines DM Valcourt, CH Kapadia, MA Scully, MN Dang, ES Day Advanced healthcare materials 9 (12), 2000110, 2020 | 18 | 2020 |
| Treating triple-negative breast cancer through nanoparticle-mediated photothermal therapy and gene regulation DM Valcourt University of Delaware, 2020 | | 2020 |
